E2F5 and central nervous system cancer: We observed that TWEAK treatment increased nuclear E2F4 and E2F5 protein levels in glioma cells, with E2F4 having greater nuclear translocation in BT25 cells and E2F5 in BT114 cells (Figure 4A).